4//SEC Filing
JOHANNESSEN JAN 4
Accession 0001214659-22-002938
CIK 0001581280other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 4:35 PM ET
Size
8.7 KB
Accession
0001214659-22-002938
Insider Transaction Report
Form 4
JOHANNESSEN JAN
Director
Transactions
- Exercise/Conversion
Common Stock
2022-02-16$14.00/sh+5,000$70,000→ 10,136 total - Sale
Common Stock
2022-02-16$59.20/sh−5,000$296,000→ 5,136 total - Exercise/Conversion
Director Stock Option (right to buy)
2022-02-16−5,000→ 22,304 totalExercise: $14.00Exp: 2028-10-29→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2021.
- [F2]1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Documents
Issuer
Twist Bioscience Corp
CIK 0001581280
Entity typeother
Related Parties
1- filerCIK 0001224168
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 4:35 PM ET
- Size
- 8.7 KB